ArticleOncology reports2019

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.

Bing Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.